Coupling Polymorphism/Solvatomorphism and Physical Stability Evaluation with Early Salt Synthesis Optimization of an Investigational Drug

The need for effective solid-form screening approaches, especially designed for the early discovery phases, is well recognized within the pharmaceutical industry. Here we report on the early polymorphism and solvatomorphism evaluation of a new drug candidate for selective α2C-adrenoceptor antagonists ORM10921·HCl. The approach we use is based on the systematic batch-to-batch characterization of the solids generated during the salt synthesis optimization. Within this study three crystalline forms, two anhydrous and one hemihydrate, were discovered and identified by X-ray powder diffraction (XRPD), differential scanning calorimery (DSC), and thermal gravimetry (TGA). Moreover, coupling the gravimetric vapor sorption analysis with a conventional XRPD enabled the relative stability of these solid-state forms at ambient conditions to be established and the most stable form, the hemihydrate, to be selected for further development. Hence, the utilized approach has proven to be an effective and fast tool for init...

[1]  J. Bernstein Polymorphism − A Perspective , 2011 .

[2]  George Zografi,et al.  Accelerating proof of concept for small molecule drugs using solid-state chemistry. , 2010, Journal of pharmaceutical sciences.

[3]  E. Kwong,et al.  Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates. , 2010, Journal of medicinal chemistry.

[4]  Ashwini Nangia,et al.  Conformational polymorphism in organic crystals. , 2008, Accounts of chemical research.

[5]  Jukka Rantanen,et al.  Hyphenated spectroscopy as a polymorph screening tool. , 2007, Journal of pharmaceutical and biomedical analysis.

[6]  V. Caron,et al.  Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g). , 2007, Journal of pharmaceutical sciences.

[7]  H. Brittain,et al.  Polymorphism and solvatomorphism 2005. , 2007, Journal of pharmaceutical sciences.

[8]  Stephen R Byrn,et al.  Designing a molecular delivery system within a preclinical timeframe. , 2007, Drug discovery today.

[9]  N. Urbanetz,et al.  Quantifying the Degree of Disorder in Micronized Salbutamol Sulfate Using Moisture Sorption Analysis , 2007, Drug development and industrial pharmacy.

[10]  Matt Peterson,et al.  Application of high throughput technologies to drug substance and drug product development , 2004, Comput. Chem. Eng..

[11]  S. Balbach,et al.  Pharmaceutical evaluation of early development candidates "the 100 mg-approach". , 2004, International journal of pharmaceutics.

[12]  Michael J Cima,et al.  High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.

[13]  W. Tong,et al.  Impact of solid state properties on developability assessment of drug candidates. , 2004, Advanced drug delivery reviews.

[14]  Orn Almarsson,et al.  High-Throughput Surveys of Crystal Form Diversity of Highly Polymorphic Pharmaceutical Compounds , 2003 .

[15]  G. Buckton,et al.  A study of the crystallisation of amorphous salbutamol sulphate using water vapour sorption and near infrared spectroscopy. , 2002, International journal of pharmaceutics.

[16]  Graham Buckton,et al.  The use of gravimetric studies to assess the degree of crystallinity of predominantly crystalline powders , 1995 .

[17]  A. Burger,et al.  On the polymorphism of pharmaceuticals and other molecular crystals. I , 1979 .

[18]  A. Burger,et al.  On the polymorphism of pharmaceuticals and other molecular crystals. II , 1979 .

[19]  F. Rappaport,et al.  Über die Verwendung von Perjodat zur maßanalytischen Bestimmung von Ketosen (Monosacchariden) , 1937 .

[20]  Jukka Rantanen,et al.  Solid form screening--a review. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  Donald C. Monkhouse,et al.  Review ArticlePharmaceutical Salts , 1977 .